The sirtuin SIRT1 is a highly conserved nicotinamide adenine dinucleotide (NAD)-dependent protein deacetylase known to have protective effects against a wide range of neurological disorders. In the present study, we discovered that C57BL/6 mice fed a long-term diet supplemented with high-dose resveratrol exhibited increased cochlear SIRT1 activity and presented a better recovery of hearing and less loss of hair cells after intense noise exposure compared with those fed a standard chew. Moreover, resveratrol attenuated cochlear SIRT1 decrease and reduced oxidative stress in the cochlea after noise exposure. These results suggest a considerable therapeutic potential of resveratrol for the treatment of noise-induced hearing loss.

Keywords:
Resveratrol, Noise exposure, Sirtuin activity
1.
Brown KD, Maqsood S, Huang JY, Pan Y, Harkcom W, Li W, Sauve A, Verdin E, Jaffrey SR: Activation of SIRT3 by the NAD(+) precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab 2014; 20: 1059–1068.
2.
Chung JH, Manganiello V, Dyck JR: Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol 2012; 22: 546–554.
3.
Cottart CH, Nivet-Antoine V, Beaudeux JL: Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans. Mol Nutr Food Res 2014; 58: 7–21.
4.
Cunningham LL, Tucci DL: Restoring synaptic connections in the inner ear after noise damage. N Engl J Med 2015; 372: 181–182.
5.
Eggermont JJ: Acquired hearing loss and brain plasticity. Hear Res 2017; 343: 176–190.
6.
Fetoni AR, De Bartolo P, Eramo SL, Rolesi R, Paciello F, Bergamini C, Fato R, Paludetti G, Petrosini L, Troiani D: Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: cochlear and cortical responses after an increase in antioxidant defense. J Neurosci 2013; 33: 4011–4023.
7.
Finkel T, Deng CX, Mostoslavsky R: Recent progress in the biology and physiology of sirtuins. Nature 2009; 460: 587–591.
8.
Henderson D, Bielefeld EC, Harris KC, Hu BH: The role of oxidative stress in noise-induced hearing loss. Ear Hear 2006; 27: 1–19.
9.
Herskovits AZ, Guarente L: SIRT1 in neurodevelopment and brain senescence. Neuron 2014; 81: 471–483.
10.
Hill K, Yuan H, Wang X, Sha SH: Noise-induced loss of hair cells and cochlear synaptopathy are mediated by the activation of AMPK. J Neurosci 2016; 36: 7497–7510.
11.
Hori YS, Kuno A, Hosoda R, Horio Y: Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PLoS One 2013; 8:e73875.
12.
Horio Y, Hayashi T, Kuno A, Kunimoto R: Cellular and molecular effects of sirtuins in health and disease. Clin Sci (Lond) 2011; 121: 191–203.
13.
Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, Riera TV, Lee JE, E SY, Lamming DW, Pentelute BL, Schuman ER, Stevens LA, Ling AJ, Armour SM, Michan S, Zhao H, Jiang Y, Sweitzer SM, Blum CA, Disch JS, Ng PY, Howitz KT, Rolo AP, Hamuro Y, Moss J, Perni RB, Ellis JL, Vlasuk GP, Sinclair DA: Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 2013; 339: 1216–1219.
14.
Imai S, Armstrong CM, Kaeberlein M, Guarente L: Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000; 403: 795–800.
15.
Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W: SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 2011; 301:F427–F435.
16.
Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T: Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 2002; 21: 2383–2396.
17.
Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W: Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001; 107: 137–148.
18.
Mizutari K, Fujioka M, Hosoya M, Bramhall N, Okano HJ, Okano H, Edge AS: Notch inhibition induces cochlear hair cell regeneration and recovery of hearing after acoustic trauma. Neuron 2013; 77: 58–69.
19.
Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L: Mammalian SIRT1 represses forkhead transcription factors. Cell 2004; 116: 551–563.
20.
Novelle MG, Wahl D, Dieguez C, Bernier M, de Cabo R: Resveratrol supplementation: where are we now and where should we go? Ageing Res Rev 2015; 21: 1–15.
21.
Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH: Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012; 148: 421–433.
22.
Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA: Sirt1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 2012; 15: 675–690.
23.
Revollo JR, Li X: The ways and means that fine tune Sirt1 activity. Trends Biochem Sci 2013; 38: 160–167.
24.
Sebastian C, Satterstrom FK, Haigis MC, Mostoslavsky R: From sirtuin biology to human diseases: an update. J Biol Chem 2012; 287: 42444–42452.
25.
Seidman M, Babu S, Tang W, Naem E, Quirk WS: Effects of resveratrol on acoustic trauma. Otolaryngol Head Neck Surg 2003; 129: 463–470.
26.
Seidman MD, Tang W, Bai VU, Ahmad N, Jiang H, Media J, Patel N, Rubin CJ, Standring RT: Resveratrol decreases noise-induced cyclooxygenase-2 expression in the rat cochlea. Otolaryngol Head Neck Surg 2013; 148: 827–833.
27.
Seo JS, Moon MH, Jeong JK, Seol JW, Lee YJ, Park BH, Park SY: SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death. Neurobiol Aging 2012; 33: 1110–1120.
28.
Sin TK, Yu AP, Yung BY, Yip SP, Chan LW, Wong CS, Ying M, Rudd JA, Siu PM: Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart. J Physiol 2014; 592: 2535–2548.
29.
Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA: Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010; 143: 802–812.
30.
Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA: hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149–159.
31.
Vousden KH: p53: death star. Cell 2000; 103: 691–694.
32.
Xiong H, Dai M, Ou Y, Pang J, Yang H, Huang Q, Chen S, Zhang Z, Xu Y, Cai Y, Liang M, Zhang X, Lai L, Zheng Y: SIRT1 expression in the cochlea and auditory cortex of a mouse model of age-related hearing loss. Exp Gerontol 2014; 51: 8–14.
33.
Xiong H, Pang J, Yang H, Dai M, Liu Y, Ou Y, Huang Q, Chen S, Zhang Z, Xu Y, Lai L, Zheng Y: Activation of miR-34a/SIRT1/p53 signaling contributes to cochlear hair cell apoptosis: implications for age-related hearing loss. Neurobiol Aging 2015; 36: 1692–1701.
34.
Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369–2380.
35.
Yuan H, Wang X, Hill K, Chen J, Lemasters J, Yang SM, Sha SH: Autophagy attenuates noise-induced hearing loss by reducing oxidative stress. Antioxid Redox Signal 2015; 22: 1308–1324.
36.
Zheng HW, Chen J, Sha SH: Receptor-interacting protein kinases modulate noise-induced sensory hair cell death. Cell Death Dis 2014; 5: e1262.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.